S. Datta and D. J. Grant, Crystal structures of drugs: advances in determination, prediction and engineering, Nature Reviews Drug Discovery, vol.3, issue.1, pp.42-57, 2004.
DOI : 10.1038/nrd1280

M. Soldani, D. Riley, and K. Mcfarland, Dealing with the impact of ritonavir polymorphs on the late stages of bulk drug process development, Organic Process Research & Development, vol.4, issue.5, pp.413-417, 2000.

I. Q6a-guideline, 1.12. Specifications: Test Procedures and Acceptance Criteria for New Drug Substances and New Drug Products. Comments for its application, pp.101-122

. Guidance, ANDAs : pharmaceutical solid polymorphism. Chemistry, manufacturing and controls information. Department of Health and Human Services. Food and Drug Administration. Center for Drug Evaluation and Research (CDER), 2007.

A. Berdeaux, E. Loueslati, J. L. Gerard, E. Pussard, and J. F. Giudicelli, EVALUATION OF THE NATRIURETIC AND BETA-ADRENOCEPTOR-BLOCKING EFFECTS OF TIENOXOLOL IN NORMAL VOLUNTEERS, Fundamental & Clinical Pharmacology, vol.6, issue.Suppl., 1988.
DOI : 10.1111/j.1365-2125.1978.tb01609.x

N. Mahé, B. Do, B. Nicolai, I. B. Rietveld, M. Barrio et al., Crystal structure and solid-state studies of aged samples of tienoxolol, an API designed against hypertension, International Journal of Pharmaceutics, vol.422, issue.1-2, pp.47-51, 2012.
DOI : 10.1016/j.ijpharm.2011.10.025

P. F. Schellhammer, An evaluation of bicalutamide in the treatment of prostate cancer, Expert Opinion on Pharmacotherapy, vol.155, issue.9, pp.1313-1328, 2002.
DOI : 10.1016/S8756-3282(97)00012-4

Y. Fradet, N. James, and J. Maher, Bicalutamide (Casodex??) in the treatment of prostate cancer, Expert Review of Anticancer Therapy, vol.31, issue.1, pp.37-48, 2004.
DOI : 10.1016/S0022-5347(01)63059-3

M. A. Cascieri, A. H. Cheung, J. R. Brooks, and C. Berman, Azasteroids ? structureactivity-relationships for inhibition of 5-ala-reductase and of androgen receptor-binding, J, 1986.

E. Ritsert, Development of anesthesine, Pharm. Ztg, vol.70, pp.1006-1008, 1925.

H. Kataoka, Y. Imamura, H. Tanaka, and M. Makita, Determination of cysteamine and cystamine by gas chromatography with flame photometric detection, Journal of Pharmaceutical and Biomedical Analysis, vol.11, issue.10, 1993.
DOI : 10.1016/0731-7085(93)80056-7

.. Notions-fondamentales-concernant-la-stabilité-chimique, 45 2.4.1. Différents types d, p.47

J. Bernstein, Polymorphism in Molecular Crystals, International Union of Crystallography. Monographs on crystallography, vol.14, 2002.
DOI : 10.1093/acprof:oso/9780199236565.001.0001

B. Rodriguez-spong, C. P. Price, A. Jayasankar, A. J. Matzger, and N. Rodriguez-homedo, General principles of pharmaceutical solid polymorphism A supramolecular perspective, Advanced Drug Delivery Reviews, vol.56, issue.3, pp.241-274, 2004.
DOI : 10.1016/j.addr.2003.10.005

R. Prohens and C. Puigjaner, Polimorfismo en la industria farmacéutica, El Farmaceutico, vol.373, pp.58-68, 2007.

H. G. Brittain, Polymorphism in Pharmaceutical Solids, 2009.

J. O. Henck, U. J. Greisser, and A. Burger, Polymorphie von Arzneistoffen. Eine Wirstschaftliche Herausforderung?, Pharm. Ind, vol.59, pp.165-174, 1997.

T. L. Threlfall, Analysis of organic polymorphs. A review, The Analyst, vol.120, issue.10, pp.2435-2460, 1995.
DOI : 10.1039/an9952002435

G. Stahly, Diversity in Single- and Multiple-Component Crystals. The Search for and Prevalence of Polymorphs and Cocrystals, Crystal Growth & Design, vol.7, issue.6, pp.1007-1026, 2007.
DOI : 10.1021/cg060838j

L. Yu, Amorphous pharmaceutical solids: preparation, characterization and stabilization, Advanced Drug Delivery Reviews, vol.48, issue.1, pp.27-42, 2001.
DOI : 10.1016/S0169-409X(01)00098-9

M. Pudipeddi and A. T. Serajuddin, Trends in Solubility of Polymorphs, Journal of Pharmaceutical Sciences, vol.94, issue.5, pp.929-939, 2005.
DOI : 10.1002/jps.20302

B. C. Hancock and M. Parks, What is the true solubility advantage of amorphous pharmaceuticals ?, Pharmaceutical Research, vol.17, issue.4, pp.397-404, 2000.
DOI : 10.1023/A:1007516718048

S. R. Byrn, Solid-State Chemistry of drugs, 1982.

A. Heinz, C. J. Strachan, K. C. Gordon, and T. Rades, Analysis of solid-state transformations of pharmaceutical compounds using vibrational spectroscopy, Journal of Pharmacy and Pharmacology, vol.71, issue.8, 2009.
DOI : 10.1016/j.ejpb.2008.06.001

K. Knapman, Polymorphic predictions : understanding the nature of crystalline compounds can be critical in drug development and manufacture, Mod. Drug Discov, vol.3, pp.53-57, 2000.

E. Doelker, Modifications cristallines et transformations polymorphes au cours des opérations galéniques, Ann. Pharm. Fr, vol.60, pp.161-176, 2002.

N. Chieng, T. Rades, and J. Aaltonen, An overview of recent studies on the analysis of pharmaceutical polymorphs, Journal of Pharmaceutical and Biomedical Analysis, vol.55, issue.4, pp.618-644, 2011.
DOI : 10.1016/j.jpba.2010.12.020

S. Byrn, R. Pfeiffer, M. Ganey, C. Hoiberg, and G. Poochikian, Pharmaceutical solids: a strategic approach to regulatory consideration, Pharmaceutical Research, vol.12, issue.7, pp.945-954, 1995.
DOI : 10.1023/A:1016241927429

G. D. Buckton, Assessment of disorder in crystalline powders??????a review of analytical techniques and their application, International Journal of Pharmaceutics, vol.179, issue.2, pp.141-158, 1999.
DOI : 10.1016/S0378-5173(98)00335-4

J. Masse, Polymorphisme cristallin et médicament. Introduction, Ann. Pharm, 2002.

I. Q6a, Specifications: Test procedures and acceptance criteria for new drug substances and new drug products: Chemical substances, 2000.

M. Barrio, D. Oliveira, P. Céolin, R. Lopez, D. O. Tamarit et al., Diagrams, Chemistry of Materials, vol.14, issue.2, pp.851-857, 2002.
DOI : 10.1021/cm0112237
URL : https://hal.archives-ouvertes.fr/hal-01532157

R. Ceolin, S. Toscani, V. Agafonov, and J. Dugué, Phenomenology of polymorphism (I): Pressure-Temperature representation of trimorphism. General rules. Application to the case of dimethyl 3,6-dichloro-2,5-dihydroxyterephthalate, Journal of Solid State Chemistry, vol.98, issue.2, pp.366-78, 1992.
DOI : 10.1016/S0022-4596(05)80247-6

R. Ceolin, S. Toscani, and J. Dugué, Phenomenology of Polymorphism, Journal of Solid State Chemistry, vol.102, issue.2, pp.465-79, 1993.
DOI : 10.1006/jssc.1993.1059

R. Ceolin, V. Agafonov, D. Louër, V. A. Dzyabchenko, S. Toscani et al., Phenomenology of Polymorphism, III:p,TDiagram and Stability of Piracetam Polymorphs, Journal of Solid State Chemistry, vol.122, issue.1, pp.186-94, 1996.
DOI : 10.1006/jssc.1996.0100

R. Ceolin and I. B. Rietveld, Phenomenology of polymorphism and topological pressure???temperature diagrams, Journal of Thermal Analysis and Calorimetry, vol.96, issue.1, pp.357-360, 2010.
DOI : 10.1002/jps.22039

I. Gana, R. Ceolin, and I. B. Rietveld, Phenomenology of polymorphism: The topological pressure???temperature phase relationships of the dimorphism of finasteride, Thermochimica Acta, vol.546, 2012.
DOI : 10.1016/j.tca.2012.07.030

J. Giovannini, L. Terminassian, R. Céolin, S. Toscani, M. A. Perrin et al., Tetramorphism of fananserine : p, T diagram and stability hierarchy from crystal structure determinations and thermodynamic studies, Le Journal de Physique IV, vol.11, issue.PR10, pp.123-126, 2001.
DOI : 10.1051/jp4:20011017

. Polymorphism-of-sulfanilamide, Stability hierarchy of alpha-, beta-and gamma-forms from energy calculations by the atom-atom potential method and from the construction of the P, T phase diagram, Pharm. Res, vol.213, pp.151-154

M. Barrio, P. Espeau, J. L. Tamarit, M. A. Perrin, N. Veglio et al., Polymorphism of Progesterone: Relative Stabilities of the Orthorhombic Phases I and II Inferred from Topological and Experimental Pressure-Temperature Phase Diagrams, Journal of Pharmaceutical Sciences, vol.98, issue.5, 2009.
DOI : 10.1002/jps.21541

M. Barrio, E. Maccaroni, I. B. Rietveld, L. Malpezzi, N. Masciocchi et al., Pressure???Temperature State Diagram for the Phase Relationships Between Benfluorex Hydrochloride Forms I and II: A Case of Enantiotropic Behavior, Journal of Pharmaceutical Sciences, vol.101, issue.3, pp.1073-1078, 2012.
DOI : 10.1002/jps.22821

J. W. Gibbs, On the equilibrium of heterogeneous substances, American Journal of Science, vol.3, issue.96, 1875.
DOI : 10.2475/ajs.s3-16.96.441

J. W. Gibbs, On the equilibrium of heterogeneous substances (concluded) Trans, 1877.

L. Yu, Inferring thermodynamic stability relationship of polymorphs from melting data, Journal of Pharmaceutical Sciences, vol.84, issue.8, pp.966-974, 1995.
DOI : 10.1002/jps.2600840812

R. N. Rao and V. Nagaraju, A overview of the recent trends in develpment of HPLC methods for determination of impurities in drugs, J. Pharmaceut. Biomed, vol.33, pp.335-337, 2003.

L. Zhou, B. Mao, T. Novak, and Z. Ge, Impurity profile tracking for act pharmaceutical ingredients : Case reports, J. Pharmaceut. Biomed, vol.4, pp.421-429, 2007.
DOI : 10.1016/j.jpba.2006.11.004

S. Ranjit and R. Zia-ur, Current trends in forced degradation study for pharmaceutical product development, J., Pharm. Educ. Res, vol.3, issue.1, 2012.

F. Qiu and D. L. Norwood, Identification of Pharmaceutical Impurities, Journal of Liquid Chromatography & Related Technologies, vol.40, issue.3, 2007.
DOI : 10.1016/j.jpba.2005.10.037

B. R. Mattews, Regulatory aspects of stability testing in Europe, 1999.

I. Q1a, Stability testing of new drug substances and products, 2003.

M. Bakshi and S. Singhi, Development of validated stability-indicating assay methods???critical review, Journal of Pharmaceutical and Biomedical Analysis, vol.28, issue.6, pp.1011-1040, 2002.
DOI : 10.1016/S0731-7085(02)00047-X

I. Q1b, Photo-stability testing of new drugs substances and products, 1996.

I. Q1c, Stability testing for new dosage forms, International Conference on Harmonization, 1996.

I. Q5c, Quality of biotechnological products: Stability testing of biotechnological / biological Products, 1995.

M. R. Ornaf and M. W. Dong, Separation science and technology. Handbook of pharmaceutical analysis by HPLC.2 Key concepts of HPLC in pharmaceutical analysis, 2005.

G. Mahuzier and M. Hamon, Abrégé de chimie analytique. II Méthodes de séparation. 2 ème édition, 1990.

D. J. Kiemle, R. M. Silverstein, and F. Webster, Identification spectrométrique de composés organiques. 2 ème édition, 2007.

T. Hatakeyama and F. X. Quinn, Thermal analysis. Fundamentals and applications to polymer science, 1999.

G. H. Höhne, W. Hemminger, and H. Flammershein, J. Diffrential scanning calorimetry. An introduction for practitioners, 1996.

C. Rawlinson, School of Pharmacy Differential scanning calorimetry, disponible sur, 2006.

J. A. Dean, The analytical chemistry handbook, pp.15-16, 1995.

E. A. Pungor, Practical guide to instrumental analysis. Boca Raton, pp.181-191, 1995.

A. Würflinger, Differential thermal analysis under high pressure IV. Low temperature DTA of solid-solid and solid-liquid transitions of several hydrocarbons up to 3, 1975.

E. Bouley, J. M. Teulon, M. Cazes, A. Cloarec, and R. Deghenghi, [p-(Thienylcarboxamido)phenoxy]propanolamine derivatives as diuretic and .beta.-adrenergic receptor blocking agents, Journal of Medicinal Chemistry, vol.29, issue.1, pp.100-103, 1986.
DOI : 10.1021/jm00151a017

. Guidance and Q. Industry, Stability Testing of New Drugs Substances and Products, International Conference on Harmonisation of Technical Requirement for Registration of Pharmaceuticals for Human Use, 2003.

L. Alana, M. H. Upthagrove, and L. W. Nelson, Mass spectral fragmentation pathways of propranolol related B-fluorinated amines studied by electrospray and electron impact ionization, Rapid Commun. Mass Spectrom, vol.13, pp.1671-1679, 1999.

K. Toth, L. Nagy, A. Mandi, A. Kui, M. Mezes et al., Collision-induced dissociation of aflatoxins, Rapid Communications in Mass Spectrometry, vol.11, issue.4, pp.553-559, 2013.
DOI : 10.1002/jcc.540110404

R. Vessechi, F. S. Emery, N. P. Lopes, and S. E. Galembeck, Electronic structure and gas-phase chemistry of protonated ??- and ??-quinonoid compounds: a mass spectrometry and computational study, Rapid Communications in Mass Spectrometry, vol.4, issue.7, 2013.
DOI : 10.1039/B610972A

R. E. March and X. S. Miao, A fragmentation study of kaempferol using electrospray quadrupole time-of-flight mass spectrometry at high mass resolution, International Journal of Mass Spectrometry, vol.231, issue.2-3, pp.157-167, 2004.
DOI : 10.1016/j.ijms.2003.10.008

M. H. Pham, M. C. Menet, A. Dugay, A. Regazzetti, D. Dauzonne et al., Characterization of monohydroxylated derivatives of the anticancer agent flavone-8-acetic acid by liquid chromatography with on-line UV and mass spectrometry, Rapid Communications in Mass Spectrometry, vol.11, issue.20, pp.3373-3386, 2007.
DOI : 10.1007/978-1-4899-2909-9_2
URL : https://hal.archives-ouvertes.fr/hal-00323882

C. Guechot, A. Bertrand, P. Cramaille, and J. M. Teulon, Analytical profile of the new diuretic beta-blocking agent tienoxolol hydrochloride, Arzneimittel-Forschung, vol.38, pp.655-660, 1988.

E. Isarain, R. M. Rodriguez, P. L. Cabot, F. Centellas, C. Arias et al., Degradation of pharmaceutical beta-blockers by electrochemical advanced oxidation processes using a flow plant with a solar compound parabolic collector, Water Research, vol.45, issue.14, pp.4119-4130, 2011.
DOI : 10.1016/j.watres.2011.05.026

M. Hubert-roux, M. Skiba, A. Sughi, M. Lahiani-skiba, F. Olivier-chanu et al., Identification of tiagabine degradation products using liquid chromatography with electrospray ionization multistage mass spectrometry and ultra-performance liquid chromatography/high-resolution mass spectrometry, Rapid Communications in Mass Spectrometry, vol.57, issue.Suppl 6, pp.287-296, 2012.
DOI : 10.1016/S0040-4020(00)01097-8
URL : https://hal.archives-ouvertes.fr/hal-00996359

P. F. Schellhammer, An evaluation of bicalutamide in the treatment of prostate cancer, Expert Opinion on Pharmacotherapy, vol.155, issue.9, pp.1313-1328, 2002.
DOI : 10.1016/S8756-3282(97)00012-4

I. I. Müderris, F. Bayram, B. Ozçelik, and M. Güven, New alternative treatment in hirsutism: bicalutamide 25 mg/day, Gynecological Endocrinology, vol.45, issue.6, pp.63-66, 2002.
DOI : 10.1016/S0090-4295(99)80077-6

D. R. Vega, G. Polla, A. Martinez, E. Mendioroz, and M. Reinoso, Conformational polymorphism in bicalutamide, International Journal of Pharmaceutics, vol.328, issue.2, pp.112-118, 2007.
DOI : 10.1016/j.ijpharm.2006.08.001

X. R. Hu and J. M. Gu, N-[4-cyan-3(trifluoromethyl)phenyl]-3-(4- fluoropheenylsulfonyl)-2-hydroxy-2-methylpropionamide, Acta Crystallogr. Sect E, 2005.
DOI : 10.1107/s1600536805034501

M. Inui and M. Ueda, Structure determination of bicalutamide polymorphic forms by powder X-ray diffraction: case studies using density functional theory calculations and Rietveld refinement, Sumitomo Kagaku, pp.39-47, 2008.

R. Persson, S. Nordholm, G. Perlovich, and L. Lindfors, Monte Carlo Studies of Drug Nucleation 1: Formation of Crystalline Clusters of Bicalutamide in Water, The Journal of Physical Chemistry B, vol.115, issue.12, pp.3062-72, 2011.
DOI : 10.1021/jp111817h

Z. Nemet, J. Sztatisz, and A. Demeter, Polymorph Transitions of Bicalutamide: A Remarkable Example of Mechanical Activation, Journal of Pharmaceutical Sciences, vol.97, issue.8, pp.3222-3254, 2008.
DOI : 10.1002/jps.21256

G. P. Andrews, O. A. Abudiak, and D. S. Jones, Physicochemical Characterization of Hot Melt Extruded Bicalutamide???Polyvinylpyrrolidone Solid Dispersions, Journal of Pharmaceutical Sciences, vol.99, issue.3, pp.1322-1357, 2010.
DOI : 10.1002/jps.21914

P. Bridgman and W. , The Physics of High Pressure, 1970.

H. Oonk, A. , and J. , Phase Theory. The Thermodynamics of Heterogeneous equilibria, 1981.

R. Ceolin, J. L. Tamarit, M. Barrio, D. O. Lopez, B. Nicola? et al., Overall Monotropic Behavior of a Metastable Phase of Biclotymol, 2,2???-Methylenebis(4-Chloro-3-Methyl-Isopropylphenol), Inferred From Experimental and Topological Construction of the Related P-T State Diagram, Journal of Pharmaceutical Sciences, vol.97, issue.9, pp.3927-3968, 2008.
DOI : 10.1002/jps.21285

L. A. Kido, A. Ciahetzl, E. M. Candido, F. Montico, R. M. Lorencini et al., Antiangiogenic and finasteride therapies: Responses of the prostate microenvironment in elderly mice, Life Sciences, vol.106, issue.1-2, pp.58-70, 2014.
DOI : 10.1016/j.lfs.2014.04.027

D. Nambiar and R. P. Singh, Advances in Prostate Cancer Chemoprevention: A Translational Perspective, Nutrition and Cancer, vol.138, issue.sup1, pp.12-25, 2013.
DOI : 10.1016/j.maturitas.2012.04.014

M. A. Cascieri, A. H. Cheung, J. R. Brooks, and C. Berman, Azasteroids ? structureactivity-relationships for inhibition of 5-ala-reductase and of androgen receptor-binding, J, 1986.

I. Wawrzycka, K. Stepniak, S. Matyjaszczyk, A. E. Koziol, T. Lis et al., Structural characterization of polymorphs and molecular complexes of finasteride, Journal of Molecular Structure, vol.474, issue.1-3, 1999.
DOI : 10.1016/S0022-2860(98)00569-9

R. M. Wenslow, M. W. Baum, R. G. Ball, J. A. Mccauley, and R. J. Varsolona, A Spectroscopic and Crystallographic Study of Polymorphism in an Aza???Steroid, Journal of Pharmaceutical Sciences, vol.89, issue.10, pp.1271-1285, 2000.
DOI : 10.1002/1520-6017(200010)89:10<1271::AID-JPS5>3.0.CO;2-6

S. Karami, Y. Li, D. S. Hughes, M. B. Hursthouse, A. E. Russel et al., Further errors in polymorph identification: furosemide and finasteride, Acta Crystallographica Section B Structural Science, vol.62, issue.4, pp.689-691, 2006.
DOI : 10.1107/S0108768106016211
URL : http://journals.iucr.org/b/issues/2006/04/00/bs5029/bs5029.pdf

N. Schultheiss, J. P. Smit, and J. A. Hanko, Three isostructural solvates of finasteride and their solid-state characterization, European Journal of Pharmaceutical Sciences, vol.38, issue.5, pp.498-503, 2009.
DOI : 10.1016/j.ejps.2009.09.014

A. Othman, J. S. Evans, I. R. Evans, R. K. Harris, and P. Hogkinson, Structural Study of Polymorphs and Solvates of Finasteride, Journal of Pharmaceutical Sciences, vol.96, issue.5, pp.1380-1397, 2007.
DOI : 10.1002/jps.20940

I. B. Rietveld, M. Barrio, J. L. Tamarit, B. Nicolai, J. Van-de-streek et al., Dimorphism of the prodrug l???tyrosine ethyl ester: Pressure???temperature state diagram and crystal structure of phase II, Journal of Pharmaceutical Sciences, vol.100, issue.11, pp.4774-4782, 2011.
DOI : 10.1002/jps.22672

E. Ritsert, Development of anesthesine, Pharm. Ztg, vol.70, pp.1006-1008, 1925.

E. J. Chan, T. R. Welberry, D. J. Goossens, A. P. Heerdegen, A. G. Beasly et al., Single-crystal diffuse scattering studies on polymorphs of molecular crystals. I. The room-temperature polymorphs of the drug benzocaine, Acta Crystallographica Section B Structural Science, vol.65, issue.3, pp.382-392, 2009.
DOI : 10.1107/S0108768109015857

B. K. Sinha and V. Pattabhi, Crystal-structure of benzocaïne ? a local-anesthetic, 1987.

M. Gruno, H. Wulff, and P. Pflegel, Polymorphism of benzocaïne, Pharmazie, vol.48, pp.834-837, 1993.

D. E. Lynch and I. Mcclenaghan, Monoclinic form of ethyl 4-aminobenzoate (benzocaine), Acta Crystallographica Section E Structure Reports Online, vol.58, issue.7, pp.708-709, 2002.
DOI : 10.1107/S1600536802009674/cv6118Isup2.hkl

E. J. Chan, A. D. Rae, and T. R. Welberry, On the polymorphism of benzocaine; a low-temperature structural phase transition for form (II), Acta Crystallographica Section B Structural Science, vol.65, issue.4, pp.509-515, 2009.
DOI : 10.1107/S0108768109018898/so5027IIIsup4.hkl

A. C. Schmidt, Structural characteristics and crystal polymorphism of three local anaesthetic bases, International Journal of Pharmaceutics, vol.298, issue.1, pp.186-197, 2005.
DOI : 10.1016/j.ijpharm.2005.04.025

P. A. Schwartz and A. N. Paruta, Solution thermodynamics of alkyl p???aminobenzoates, Journal of Pharmaceutical Sciences, vol.65, issue.2, pp.252-257, 1976.
DOI : 10.1002/jps.2600650219

R. H. Manzo and A. A. Ahumada, Effects of solvent medium on solubility, 1990.

S. H. Yalkowsky, T. G. Slunick, and G. L. Flunn, Importance of chain length on physicochemical and crystalline properties of organic homologs, Journal of Pharmaceutical Sciences, vol.61, issue.6, pp.852-857, 1972.
DOI : 10.1002/jps.2600610604

F. L. Nordstrom and A. C. Rasmuson, Prediction of solubility curves and melting properties of organic and pharmaceutical compounds, European Journal of Pharmaceutical Sciences, vol.36, issue.2-3, pp.330-344, 2009.
DOI : 10.1016/j.ejps.2008.10.009

J. S. Chickos, G. Nichols, and P. Ruelle, The Estimation of Melting Points and Fusion Enthalpies Using Experimental Solubilities, Estimated Total Phase Change Entropies, and Mobile Order and Disorder Theory, Journal of Chemical Information and Computer Sciences, vol.42, issue.2, pp.368-374, 2002.
DOI : 10.1021/ci010341b

A. Garmroodi, J. Hassan, and Y. Tamini, Solubilities of the Drugs Benzocaine, Metronidazole Benzoate, and Naproxen in Supercritical Carbon Dioxide, Journal of Chemical & Engineering Data, vol.49, issue.3, pp.709-712, 2004.
DOI : 10.1021/je020218w

S. H. Neau, G. L. Flynn, and S. H. Yalkowsky, The influence of heat capacity assumptions on the estimation of solubility parameters from solubility data, International Journal of Pharmaceutics, vol.49, issue.3, pp.223-229, 1989.
DOI : 10.1016/0378-5173(89)90346-3

S. H. Neau and G. L. Flynn, Solid and liquid heat-capacities of normal-alkyl paraaminobenzoates near the melting-point, Pharmaceutical Research, vol.07, issue.11, pp.1157-1162, 1990.
DOI : 10.1023/A:1015984310068

R. Ceolin and I. Rietveld, Phenomenology of polymorphism and topological pressure???temperature diagrams, Journal of Thermal Analysis and Calorimetry, vol.96, issue.1, pp.357-360, 2010.
DOI : 10.1002/jps.22039

I. B. Rietveld, M. Barrio, B. Do, J. L. Tamarit, and R. Ceolin, Overall Stability for the Ibuprofen Racemate: Experimental and Topological Results Leading to the Pressure???Temperature Phase Relationships between Its Racemate and Conglomerate, The Journal of Physical Chemistry B, vol.116, issue.18, pp.5568-5574, 2012.
DOI : 10.1021/jp302508g

I. B. Rietveld, M. A. Perrin, S. Toscani, M. Barrio, B. Nicolai et al., Liquid???Liquid Miscibility Gaps in Drug???Water Binary Systems: Crystal Structure and Thermodynamic Properties of Prilocaine and the Temperature???Composition Phase Diagram of the Prilocaine???Water System, Molecular Pharmaceutics, vol.10, issue.4, pp.1332-1339, 2013.
DOI : 10.1021/mp300542k
URL : https://hal.archives-ouvertes.fr/hal-01236465

. Acdlabs, Advanced Chemistry Development (ACD/Labs) software, V11

J. D. Dunitz and J. Bernstein, Disappearing Polymorphs, Accounts of Chemical Research, vol.28, issue.4, pp.193-200, 0197.
DOI : 10.1021/ar00052a005

H. Kataoka, H. Tanaka, and M. Makita, Determination of total cysteamine in urine and plasma samples by gas chromatography with flame photometric detection, Journal of Chromatography B: Biomedical Sciences and Applications, vol.657, issue.1, 1994.
DOI : 10.1016/0378-4347(94)80063-4

C. H. Kim, S. Parkin, M. Bharara, and D. Atwood, Linear coordination of Hg(II) by cysteamine, Polyhedron, vol.21, issue.2, pp.225-228, 2002.
DOI : 10.1016/S0277-5387(01)00978-0

S. Ahmad, M. A. Shaheen, and H. Stoeckli-evans, A monoclinic polymorph of cysteamine hydrochloride, Acta Crystallographica Section E Structure Reports Online, vol.65, issue.1, p.134, 2010.
DOI : 10.1107/S1600536809053008/is2503Isup2.hkl

M. Lahiani-skiba, Y. Boulet, I. Youm, F. Bounoure, P. Verite et al., Interaction between hydrophilic drug and ??-cyclodextrins: physico-chemical aspects, Journal of Inclusion Phenomena and Macrocyclic Chemistry, vol.31, issue.8, 2007.
DOI : 10.1111/j.2042-7158.1994.tb03889.x

I. Gana, A. Dugay, T. Henriet, I. B. Rietveld, M. Bernard et al., Degradation pathways study of the natriuretic and ??-adrenoceptor antagonist tienoxolol using liquid chromatography???electrospray ionization multistage mass spectrometry, Journal of Pharmaceutical and Biomedical Analysis, vol.96, pp.58-67, 2014.
DOI : 10.1016/j.jpba.2014.03.016

M. Barrio, P. De-oliveria, R. Céolin, D. O. Lopez, and J. Tamarit, Diagrams, Chemistry of Materials, vol.14, issue.2, pp.851-857, 2002.
DOI : 10.1021/cm0112237
URL : https://hal.archives-ouvertes.fr/hal-01532157

R. Ceolin, S. Toscani, V. Agafonov, and J. Dugue, Phenomenology of polymorphism (I): Pressure-Temperature representation of trimorphism. General rules. Application to the case of dimethyl 3,6-dichloro-2,5-dihydroxyterephthalate, Journal of Solid State Chemistry, vol.98, issue.2, pp.366-78, 1992.
DOI : 10.1016/S0022-4596(05)80247-6

R. Ceolin, S. Toscani, and J. Dugue, Phenomenology of Polymorphism, Journal of Solid State Chemistry, vol.102, issue.2, pp.465-79, 1993.
DOI : 10.1006/jssc.1993.1059

R. Ceolin, V. Agafonov, D. Louer, V. A. Dzyabchenko, S. Toscani et al., Phenomenology of Polymorphism, III:p,TDiagram and Stability of Piracetam Polymorphs, Journal of Solid State Chemistry, vol.122, issue.1, pp.186-94, 1996.
DOI : 10.1006/jssc.1996.0100

I. Gana, R. Ceolin, and I. B. Rietveld, Bicalutamide polymorphs I and II, Journal of Thermal Analysis and Calorimetry, vol.101, issue.1, pp.223-228, 2013.
DOI : 10.1002/jps.22821

R. Ceolin, J. L. Tamarit, M. Barrio, D. O. Lopez, B. Nicolay et al., Overall Monotropic Behavior of a Metastable Phase of Biclotymol, 2,2???-Methylenebis(4-Chloro-3-Methyl-Isopropylphenol), Inferred From Experimental and Topological Construction of the Related P-T State Diagram, Journal of Pharmaceutical Sciences, vol.97, issue.9, pp.3927-3941, 2008.
DOI : 10.1002/jps.21285

J. Ledru, C. T. Imrie, C. R. Pulham, R. Ceolin, and J. M. Hutchinson, High Pressure Differential Scanning Calorimetry Investigations on the Pressure Dependence of the Melting of Paracetamol Polymorphs I and II, Journal of Pharmaceutical Sciences, vol.96, issue.10, pp.2784-2794, 2007.
DOI : 10.1002/jps.20903

I. Rietveld, M. Barrio, P. Espeau, J. Tamarit, and R. Ceolin, -Camphor, The Journal of Physical Chemistry B, vol.115, issue.7, pp.1672-1678, 2011.
DOI : 10.1021/jp108900v

R. Rotival, P. Espeau, Y. Corvis, F. Guyon, and B. Do, Determination of quinacrine dihydrochloride dehydrate stability and characterization of its degradants, J, 2010.

P. Lemoine and P. Espeau, Comprehensive determination of the solid state stability of bethanechol chloride active pharmaceutical ingredient using combined analytical tools, 2013.
URL : https://hal.archives-ouvertes.fr/hal-00874391